Fact CheckerSign in

NCT07810361Not yet recruiting

Combined Inspiratory Muscle Training and Functional High-Intensity Interval Training in Boys With Obesity

Combined Inspiratory Muscle Training and Functional High-Intensity Interval Training Promote Respiratory, Diaphragmatic, and Aerobic Adaptations in Children With Obesity

Source: ClinicalTrials.gov · Last updated 9 Sept 2026

Brief summary (registry, in English)

Childhood obesity is associated with reduced cardiorespiratory fitness, impaired exercise tolerance, and altered respiratory mechanics. This randomized controlled trial investigated whether combining inspiratory muscle training with functional high-intensity interval training improves diaphragm morphology, respiratory muscle strength, pulmonary function, aerobic fitness, and functional exercise capacity in boys with obesity. Fifty boys aged 10-12 years were randomly assigned to six weeks of combined inspiratory muscle training and functional high-intensity interval training or usual activity.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
1 Sept 2026
Start date
20 Oct 2026
Primary completion date
15 Dec 2026
Lead sponsor
Gümüşhane Universıty
Diseases
Obesity
NCT number
NCT07810361

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 20 Oct 2026 to the primary completion date, 15 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Medication use that could affect respiratory function or exercise capacity.
  • Previous thoracic surgery.

Other illness

  • Diagnosed cardiovascular, neuromuscular, orthopaedic, or metabolic conditions that could interfere with exercise participation.
  • Chronic respiratory disease, including asthma requiring regular medication.
  • Impaired pulmonary function defined as FEV₁/FVC \<75%.
    • \*Upper respiratory tract infection within the preceding two weeks.

Other

  • Inability to complete the testing procedures.

Who the study is looking for

  • Male sex.
  • Age 10-12 years.
    • \*Obesity according to World Health Organization age- and sex-specific BMI reference criteria.
  • No regular participation in structured exercise training during the preceding six months.
  • Medical clearance to participate in moderate-to-vigorous physical activity.

Age in the registry: 10 years to 12 years · Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gumushane Üniversity
Coordinator of this site? Confirm its status
TrabzonTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.